ECT2 and cancer: An opposed status was observed when we considered the phosphorylation status of ECT2 in cancerous tissues versus normal ones as several positions, including T395, S367, S443, T444, T857, S858, S861, T373, S442, T359, and S866, demonstrated hyperphosphorylation in several human cancers.